OMCL – Omnicell, Inc.
Omnicell, Inc.OMCL
$34.19Name : Omnicell, Inc.
Sector : Healthcare
Industry: Health Information Services
Mark. Cap: $1,570,492,032.00
EPSttm : 0.43
Omnicell, Inc.
$34.19
2.65%$0.93Float Short %
4.4
Margin Of Safety %
10
Put/Call OI Ratio
0.44
EPS Next Q Diff
-0.01
EPS Last/This Y
1.44
EPS This/Next Y
0.13
Price
34.23
Target Price
47.33
Analyst Recom
1.75
Performance Q
7.15
Relative Volume
0.75
Beta
0.82
Ticker: OMCL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | OMCL | 30.2 | 0.46 | 0.05 | 462 |
| 2025-10-21 | OMCL | 30.98 | 0.44 | 0.00 | 484 |
| 2025-10-22 | OMCL | 30.4 | 0.43 | 0.00 | 485 |
| 2025-10-23 | OMCL | 30.86 | 0.42 | 0.00 | 497 |
| 2025-10-24 | OMCL | 31.08 | 0.42 | 999.99 | 496 |
| 2025-10-27 | OMCL | 30.49 | 0.44 | 2.00 | 503 |
| 2025-10-28 | OMCL | 29.95 | 0.46 | 1.25 | 509 |
| 2025-10-29 | OMCL | 29.54 | 0.48 | 0.40 | 514 |
| 2025-10-30 | OMCL | 33.61 | 0.48 | 0.50 | 515 |
| 2025-10-31 | OMCL | 33.73 | 0.48 | 0.17 | 518 |
| 2025-11-03 | OMCL | 33.32 | 0.48 | 0.17 | 518 |
| 2025-11-04 | OMCL | 34.52 | 0.47 | 0.53 | 522 |
| 2025-11-05 | OMCL | 35.72 | 0.47 | 0.08 | 535 |
| 2025-11-06 | OMCL | 35.76 | 0.44 | 0.00 | 569 |
| 2025-11-07 | OMCL | 35.69 | 0.43 | 0.00 | 577 |
| 2025-11-10 | OMCL | 36.83 | 0.42 | 0.00 | 581 |
| 2025-11-11 | OMCL | 37.1 | 0.42 | 2.00 | 588 |
| 2025-11-12 | OMCL | 36.86 | 0.41 | 0.17 | 585 |
| 2025-11-13 | OMCL | 35.53 | 0.41 | 0.33 | 585 |
| 2025-11-14 | OMCL | 35.13 | 0.41 | 1.17 | 586 |
| 2025-11-17 | OMCL | 34.18 | 0.44 | 0.00 | 605 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | OMCL | 30.20 | -35.3 | - | 1.55 |
| 2025-10-21 | OMCL | 30.97 | -35.3 | - | 1.55 |
| 2025-10-22 | OMCL | 30.45 | -35.3 | - | 1.55 |
| 2025-10-23 | OMCL | 30.88 | -35.3 | - | 1.55 |
| 2025-10-24 | OMCL | 31.09 | -35.3 | - | 1.55 |
| 2025-10-27 | OMCL | 30.49 | -35.3 | - | 1.55 |
| 2025-10-28 | OMCL | 29.94 | -35.3 | - | 1.55 |
| 2025-10-29 | OMCL | 29.57 | -35.3 | - | 1.55 |
| 2025-10-30 | OMCL | 33.58 | -35.3 | - | 1.55 |
| 2025-10-31 | OMCL | 33.57 | -35.3 | - | 1.55 |
| 2025-11-03 | OMCL | 33.33 | -19.8 | - | 1.64 |
| 2025-11-04 | OMCL | 34.51 | -20.4 | - | 1.67 |
| 2025-11-05 | OMCL | 35.73 | -20.4 | - | 1.67 |
| 2025-11-06 | OMCL | 35.76 | -19.0 | - | 1.71 |
| 2025-11-07 | OMCL | 35.68 | -19.0 | - | 1.71 |
| 2025-11-10 | OMCL | 36.81 | -18.5 | - | 1.71 |
| 2025-11-11 | OMCL | 37.11 | -18.5 | - | 1.71 |
| 2025-11-12 | OMCL | 36.84 | -18.5 | - | 1.71 |
| 2025-11-13 | OMCL | 35.56 | -18.5 | - | 1.71 |
| 2025-11-14 | OMCL | 35.10 | -18.5 | - | 1.71 |
| 2025-11-17 | OMCL | 34.23 | -18.5 | - | 1.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | OMCL | -0.25 | 0.15 | 4.39 |
| 2025-10-21 | OMCL | -0.29 | 0.15 | 4.39 |
| 2025-10-22 | OMCL | -0.29 | 0.15 | 4.39 |
| 2025-10-23 | OMCL | -0.29 | 0.15 | 4.39 |
| 2025-10-24 | OMCL | -0.29 | 0.15 | 4.39 |
| 2025-10-27 | OMCL | -0.29 | 0.31 | 4.32 |
| 2025-10-28 | OMCL | -0.29 | 0.31 | 4.32 |
| 2025-10-29 | OMCL | -0.29 | 0.31 | 4.32 |
| 2025-10-30 | OMCL | -0.29 | 0.31 | 4.32 |
| 2025-10-31 | OMCL | -0.29 | 0.31 | 4.32 |
| 2025-11-03 | OMCL | -0.29 | 0.38 | 4.32 |
| 2025-11-04 | OMCL | -0.29 | 0.38 | 4.32 |
| 2025-11-05 | OMCL | -0.29 | 0.38 | 4.32 |
| 2025-11-06 | OMCL | -0.29 | 0.38 | 4.32 |
| 2025-11-07 | OMCL | -0.29 | 0.38 | 4.32 |
| 2025-11-10 | OMCL | -0.29 | 0.46 | 4.43 |
| 2025-11-11 | OMCL | -0.29 | 0.46 | 4.43 |
| 2025-11-12 | OMCL | -0.29 | 0.46 | 4.40 |
| 2025-11-13 | OMCL | -0.29 | 0.46 | 4.40 |
| 2025-11-14 | OMCL | -0.29 | 0.46 | 4.40 |
| 2025-11-17 | OMCL | -0.29 | 6.94 | 4.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.32
Avg. EPS Est. Current Quarter
0.49
Avg. EPS Est. Next Quarter
0.31
Insider Transactions
-0.29
Institutional Transactions
6.94
Beta
0.82
Average Sales Estimate Current Quarter
313
Average Sales Estimate Next Quarter
281
Fair Value
37.73
Quality Score
44
Growth Score
71
Sentiment Score
44
Actual DrawDown %
81.7
Max Drawdown 5-Year %
-86.6
Target Price
47.33
P/E
80.18
Forward P/E
18.61
PEG
11.04
P/S
1.3
P/B
1.26
P/Free Cash Flow
13.76
EPS
0.43
Average EPS Est. Cur. Y
1.71
EPS Next Y. (Est.)
1.84
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
1.69
Relative Volume
0.75
Return on Equity vs Sector %
-25.3
Return on Equity vs Industry %
-13.5
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.15
EBIT Estimation
Omnicell, Inc.Sector: Healthcare
Industry: Health Information Services
Employees: 3600
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.
stock quote shares OMCL – Omnicell, Inc. Stock Price stock today
news today OMCL – Omnicell, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMCL – Omnicell, Inc. yahoo finance google finance
stock history OMCL – Omnicell, Inc. invest stock market
stock prices OMCL premarket after hours
ticker OMCL fair value insiders trading